Division of Allergy Pulmonary and Critical Care Medicine


Acetaminophen shows promise in warding off acute respiratory distress syndrome, organ injury in patients with sepsis

Findings from NIH-supported clinical trial suggest that intravenous acetaminophen has the greatest benefit in the sickest patients.

(iStock image)

New tool helps identify babies at high risk for RSV

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).

Julie Bastarache, MD (photo by Donn Jones)

Julie Bastarache elected VP of clinical investigation society

Julie Bastarache, MD, Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center, has been elected vice president of the American Society for Clinical Investigation (ASCI) for 2024-2025.

Anna Hemnes, MD

Anna Hemnes named director of the Division of Allergy, Pulmonary and Critical Care Medicine

Anna Hemnes, MD, has been named director of the Division of Allergy, Pulmonary and Critical Care Medicine, physician-in-chief of the Vanderbilt Lung Institute and director of the Center for Lung Research.

NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

VUMC mourns loss of renowned pulmonary medicine physician-scientist John H. Newman

John H. Newman, MD, an acclaimed physician-scientist in Vanderbilt University Medical Center’s Division of Allergy, Pulmonary and Critical Care Medicine who made numerous contributions to the knowledge of pulmonary vascular disease, died on Tuesday, Feb. 20, after a several-month illness. He was 78.

1 2 3 10